Medical/Pharmaceuticals
Nolato acquires US-based medtech manufacturer with annual sales of approximately SEK 1.8 billion
TOREKOV, Sweden, Aug. 6, 2020 /PRNewswire/ -- Nolato has signed an agreement to acquire US-based GW Plastics. The company, which was founded in 1955, has annual sales of approximatelySEK 1.8 billion and an EBITA margin of around 7%. The acquisition price, including contingent consideration, is es...
2020-08-06 13:34
12449
FDA issues Emergency Use Authorization to Vela Diagnostics' coronavirus PCR test
FAIRFIELD, N.J., Aug. 6, 2020 /PRNewswire/ -- Vela Diagnostics announced that the manual version of its coronavirus PCR test has obtained Emergency Use Authorization from the U.S. Food and Drug Administration (FDA). By targeting conserved regions of the viral genome, the probe-based reverse trans...
2020-08-06 11:42
3495
Johnson & Johnson Announces Agreement with U.S. Government for 100 Million Doses of Investigational COVID-19 Vaccine
NEW BRUNSWICK, New Jersey, Aug. 5, 2020 /PRNewswire/ -- Johnson & Johnson (NYSE: JNJ) (the Company) today announced its Janssen Pharmaceutical Companies have entered into an agreement with the U.S. government for the large scale domestic manufacturing and delivery in the U.S. of 100 million doses...
2020-08-05 20:30
6809
Colorcon Opens New Technical Centre in Melbourne, Australia to support the growing local pharmaceutical industry
HARLEYSVILLE, Penn., Aug. 5, 2020 /PRNewswire/ -- Colorcon, a world leader in the development and supply of film coating systems and excipients, today announces the opening of a new technical center inMelbourne, Australia. The facility provides customers in Australasia access to pharmaceutical cl...
2020-08-05 05:00
3467
World Federation of Hemophilia (WFH) publishes "The WFH Guidelines for the Management of Hemophilia, 3rd edition"
MONTREAL, Aug. 4, 2020 /PRNewswire/ -- Led by content leads, Alok Srivastava, MD, andGlenn Pierce, MD, PhD, WFH Vice-President, Medical, this 3rd edition of the World Federation of Hemophilia (WFH) Guidelines for the Management of Hemophilia offers up-to-date guidance and practical recommendation...
2020-08-04 17:00
2423
Adagio Medical, Inc., reports pre-clinical effectiveness combining their existing ultra-low temperature cryoablation catheter with Pulsed Field Ablation (PFA) in a single Pulsed Field Cryoablation (PFCA) catheter
LAGUNA HILLS, California, Aug. 4, 2020 /PRNewswire/ -- Adagio Medical, Inc., a leading innovator for the treatment of atrial fibrillation (AFib) and ventricular tachycardia (VT), and developer of theintelligent Continuous Lesion Ablation System (iCLAS™), today announced successful pre-clinical re...
2020-08-04 10:16
2933
Macrogen Obtains Europe's CE-IVD Certificate for its COVID-19 Test Kit
SEOUL, South Korea, Aug. 4, 2020 /PRNewswire/ -- The Korean biotech company
Macrogen
2020-08-04 10:00
4603
TB Alliance Announces European Commission Authorisation of New Treatment for Highly Drug-Resistant Tuberculosis
Pretomanid, developed by the non-profit TB Alliance, has received EU marketing authorisation in combination regimen with bedaquiline and linezolid in adults with XDR-TB or treatment-intolerant/non-responsive MDR-TB PRETORIA, South Africa, Aug. 3, 2020 /PRNewswire/ -- Pretomanid, a novel compound...
2020-08-03 21:13
3023
World's First 3D Regenerative Implant and Regenerative Surgical Technique To Regrow Man's Skull
SINGAPORE, Aug. 3, 2020 /PRNewswire/ -- Osteopore International Pte Ltd, a Singapore-headquartered company leading the way in regenerative bone implants, is proud to announce the success of its technology in a new medical procedure that took place inBrisbane, Australia, in December last year. Pio...
2020-08-03 14:00
3790
Innovent Announces First Patient Dosed in the Phase 1 Clinical Trial of Anti-CD47/PD-L1 Bispecific Antibody in China
SUZHOU, China, Aug. 3, 2020 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent" or "the Company") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, metabolic, autoimmune and other major dise...
2020-08-03 08:00
9064
Brain Navi Develops New Robot Performing Nasal Swab Tests to Prevent Cross Infections
HSINCHU, July 31, 2020 /PRNewswire/ -- Inspired by the pandemic, Brain Navi developed a new robot to perform nasal swab tests autonomously to prevent cross infections so we can save the medical system and reestablish economies. The coronavirus caused the lock-in policy over the world. To reopen a...
2020-07-31 15:19
4802
Harbour BioMed Announces Strategic Partnership with Viva Biotech to Collaborate on Incubating Innovative Biotech Start-ups
CAMBRIDGE, Mass. and ROTTERDAM, Netherlands and SUZHOU, SHANGHAI, China, July 31, 2020 /PRNewswire/ -- Harbour BioMed (HBM), a global clinical stage biopharmaceutical company and Viva Biotech (Shanghai) Ltd. ("Viva Biotech"), a world-leading structure-based drug discovery platform today announced...
2020-07-31 08:56
5485
Ascletis' All-oral HCV Treatment Approved for Marketing in China
HANGZHOU and SHAOXING, China, July 31, 2020 /PRNewswire/ -- Ascletis Pharma Inc. (HKEX code: 1672) announces today that its all-oral HCV treatment has been approved for marketing inChina by National Medical Products Administration (NMPA). The Company's all-oral HCV treatment (RDV/DNV Regimen) is ...
2020-07-31 08:47
9971
INOVIO's COVID-19 DNA Vaccine INO-4800 Provides Protection with Memory Immune Responses In Non-Human Primates Challenged with SARS-CoV-2 Virus
- INO-4800 showed durable antibody and T cell responses in rhesus macaques for 4 months - INO-4800 is the only vaccine to demonstrate long-term protection in non-human primates challenged with SARS-CoV-2 virus 13 weeks from vaccination - Memory T and B cell responses resulted in reduced viral l...
2020-07-30 20:34
6067
LimaCorporate Is The First Italian Company To Obtain The EU Quality Certificate Under The MDR
SAN DANIELE DEL FRIULI, Italy, July 30, 2020 /PRNewswire/ -- LimaCorporate announces that it is the first Italian company to obtain the EU Quality Management System certificate under the new European Medical Devices Regulation (MDR) from TÜV SÜD. In 2015, LimaCorporate formalized the development ...
2020-07-30 20:00
4487
Single Dose of Johnson & Johnson COVID-19 Vaccine Candidate Demonstrates Robust Protection in Pre-clinical Studies
Study published in Nature shows J&J's investigational SARS-CoV-2 vaccine elicits a strong immune response that protects against subsequent infection First-in-human Phase 1/2a clinical trial now underway in United States and Belgium; Phase 3 clinical trial expected to commence in September NEW BR...
2020-07-30 17:55
10447
MagniProtect by Magniflex: the world's first antiviral sleep collection tested against COVID-19 is Made in Italy
FLORENCE, Italy, July 30, 2020 /PRNewswire/ -- The innovative technology
developed by Magniflex inhibits the persistence of bacteria and viruses on
fabrics and has been specifically tested against SARS-COV-2.
2020-07-30 14:00
4979
Henlius and Accord Healthcare Receive EMA Approval for Zercepac®, trastuzumab biosimilar
SHANGHAI, July 30, 2020 /PRNewswire/ -- The European Commission (EC) has approved Shanghai Henlius Biotech, Inc. (2696.HK) and Accord Healthcare Limited (Accord)'s Zercepac®, a biosimilar trastuzumab, for the treatment of certain patients with HER2-positive early breast cancer, HER2-positive meta...
2020-07-30 08:00
5553
Dony Garment joins the global fight against the COVID-19
HANOI, Vietnam, July 30, 2020 /PRNewswire/ -- The coronavirus pandemic has brought about grim adversities worldwide. However, it also presents exclusive chances for small companies to expand productions and build business networks in major markets. Dony Garment, a Vietnamese garment production co...
2020-07-30 06:00
4215
Direct Biologics Receives FDA Approval to Initiate 'EXIT-COVID-19,' a Phase II Investigational New Drug Trial
AUSTIN, Texas, July 30, 2020 /PRNewswire/ -- Direct Biologics, LLC, is announcing today that it has received approval from FDA that it may proceed with a Phase II trial under an Investigational New Drug (IND) application for the use of ExoFlo™, a bone marrow-derived extracellular vesicle and exos...
2020-07-30 04:27
2733
Week's Top Stories
Most Reposted
Rocket Travel by Agoda Shares Revealing New Report and Showcases Solution to Transform Hotel Distribution
[Picked up by 313 media titles]
2024-11-21 10:30Rockwell Automation and Microsoft Deliver on a Shared Vision to Accelerate Industrial Transformation
[Picked up by 308 media titles]
2024-11-20 13:29Durabook and Parent Company, Twinhead International Corp., Celebrate 40 Years of Innovation in Computing Solutions
[Picked up by 301 media titles]
2024-11-20 16:30
Travel loyalty programs to focus on offering personalized and flexible customer experiences in 2025
[Picked up by 298 media titles]
2024-11-19 10:42Philips and Edith Cowan University Australia Collaborate to Equip the Next Generation of Healthcare Professionals to leverage new technologies
[Picked up by 284 media titles]
2024-11-20 09:00
Most Read
Durabook and Parent Company, Twinhead International Corp., Celebrate 40 Years of Innovation in Computing Solutions
2024-11-20 16:30
6217
